The male participants with NAFLD were younger, had lower HDL cholesterol, and higher SBP, DBP, prevalence rates of hyperlipidemia and MetS, and higher AST, ALT, fasting glucose, TG, uric acid, BMI, WHtR, WHR, LAP, BRI, CI, VAI, BAI, AVI, TyG index, and HSI compared to the male participants without NAFLD. The gene discussed is GPT; the disease is hyperlipidemia.